7Baggers
 Annexon price target lowered to $8 from $9 at BofA  TipRanks Sun, 16 Nov 2025 15:59:22 GMT
 Annexon raises $86.25 million in public offering of common stock By Investing.com  Investing.com Canada Sat, 15 Nov 2025 07:31:25 GMT
 Annexon Biosciences Completes Successful Public Offering  TipRanks Fri, 14 Nov 2025 22:12:45 GMT
 Annexon raises $86.25 million in public offering of common stock  Investing.com Fri, 14 Nov 2025 21:25:48 GMT
 Annexon Announces Closing of Public Offering and Full  GlobeNewswire Fri, 14 Nov 2025 21:01:00 GMT
 ANX1502 proof-of-concept trial to wrap up next year, Annexon says  Cold Agglutinin Disease News Fri, 14 Nov 2025 16:37:20 GMT
 Drug developer Annexon slips after $75 million capital raise  TradingView Thu, 13 Nov 2025 17:31:13 GMT
 Annexon launches $75M public offering of common stock  MSN Thu, 13 Nov 2025 17:21:08 GMT
 Annexon Prices $75 Million Public Offering  MarketScreener Thu, 13 Nov 2025 09:09:25 GMT
 ANNX Stock Offering Priced Within Target Range  GuruFocus Thu, 13 Nov 2025 05:24:52 GMT
 Annexon prices public offering of shares at $2.60 each By Investing.com  Investing.com Nigeria Thu, 13 Nov 2025 05:19:17 GMT
 Annexon, Inc. Announces Pricing of $75 Million Underwritten Public Offering  Quiver Quantitative Thu, 13 Nov 2025 04:00:00 GMT
 Annexon prices public offering of 25,096,153 shares at $2.60 each  MarketScreener Thu, 13 Nov 2025 03:58:15 GMT
 annexon stock falls after $75 million public offering announcement by investing.com  Investing.com Australia Thu, 13 Nov 2025 02:31:11 GMT
 Annexon announces $75M common stock, warrants offering  TipRanks Thu, 13 Nov 2025 00:31:50 GMT
 Annexon stock falls after $75 million public offering announcement  Investing.com Wed, 12 Nov 2025 22:32:52 GMT
 Annexon launches $75 million public offering of common stock  Investing.com India Wed, 12 Nov 2025 22:16:02 GMT
 annexon launches $75m public offering of common stock  MSN Wed, 12 Nov 2025 21:31:36 GMT
 symbol__ stock quote price and forecast  CNN Wed, 12 Nov 2025 18:56:15 GMT
 Annexon (ANNX) Advances in Neuroinflammation Treatment Strategy  GuruFocus Tue, 11 Nov 2025 04:58:21 GMT
 TD Cowen Maintains Annexon(ANNX.US) With Buy Rating  富途牛牛 Tue, 11 Nov 2025 04:32:00 GMT
 Annexon Biosciences Reports Increased R&D Expenses  TipRanks Tue, 11 Nov 2025 04:19:59 GMT
 annexon (annx) advances in neuroinflammation treatment strategy  GuruFocus Mon, 10 Nov 2025 22:33:16 GMT
 Annexon reports Q3 EPS (37c), consensus (34c)  TipRanks Mon, 10 Nov 2025 22:23:37 GMT
 Annexon Q3 net loss widens to $54.9 mln  TradingView Mon, 10 Nov 2025 21:20:39 GMT
 vanguard group inc's strategic acquisition of annexon inc shares  GuruFocus Thu, 06 Nov 2025 01:18:45 GMT
 Vanguard Group Inc's Strategic Acquisition of Annexon Inc Shares  GuruFocus Wed, 05 Nov 2025 08:00:00 GMT
 is annexon ready to translate its science into approvals?  RTTNews Tue, 04 Nov 2025 05:50:00 GMT

Annexon, Inc
(NASDAQ:ANNX) 

ANNX stock logo

Annexon, Inc., a clinical-stage biopharmaceutical company, engages in developing therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its products in pipelines are focused on antibody-mediated autoimmune and complement-mediated neurodegenerative disorders....

Founded: 2011
Full Time Employees: 38
CEO: Douglas Love  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends